Home › FDA clears expanded use of Pfizer's breast cancer med IBRANCE
 

Keywords :   


FDA clears expanded use of Pfizer's breast cancer med IBRANCE

2016-02-20 09:04:41| Biotech - Topix.net

The FDA approves Pfizer's supplement New Drug Application for IBRANCE . It is now cleared for the treatment of hormone receptor-positive , human epidermal growth factor receptor 2-negative advanced/metastatic breast cancer in combination with fulvestrant [AstraZeneca's FASLODEX ] in women with disease progression following endocrine therapy.

Tags: med expanded cancer breast

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
More »